Mira Pharmaceuticals Inc MIRA
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if MIRA is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- $0.90
- Day Range
- $0.85–0.92
- 52-Week Range
- $0.76–7.98
- Bid/Ask
- $0.86 / $0.90
- Market Cap
- $12.71 Mil
- Volume/Avg
- 186 / 717,438
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Stock Style Box
- —
- Total Number of Employees
- 6
Valuation
|
Metric
|
MIRA
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 3.04 |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
MIRA
|
|---|---|
Quick Ratio | 8.27 |
Current Ratio | 8.70 |
Interest Coverage | −2.47 |
Quick Ratio
MIRA
Profitability
|
Metric
|
MIRA
|
|---|---|
Return on Assets (Normalized) | −247.78% |
Return on Equity (Normalized) | −417.30% |
Return on Invested Capital (Normalized) | −210.45% |
Return on Assets
MIRA
Drug Manufacturers - General Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
LLY
| Eli Lilly and Co | Mybtjbfsz | Rqk | $697.4 Bil | |
JNJ
| Johnson & Johnson | Stfmnlhbm | Pdlj | $353.8 Bil | |
MRK
| Merck & Co Inc | Lbxgtjm | Vvwx | $332.3 Bil | |
ABBV
| AbbVie Inc | Vkghzncj | Yzlgq | $282.6 Bil | |
AZN
| AstraZeneca PLC ADR | Qgddphtbb | Nkfbt | $232.3 Bil | |
NVS
| Novartis AG ADR | Ssxrqhktj | Mfpt | $200.1 Bil | |
RHHBY
| Roche Holding AG ADR | Yxtrghfcq | Mprrq | $195.3 Bil | |
AMGN
| Amgen Inc | Spdcqcdqt | Zss | $144.5 Bil | |
PFE
| Pfizer Inc | Lwmhvdfwb | Vld | $143.8 Bil | |
SNY
| Sanofi SA ADR | Khmxxrhkv | Nhfr | $122.2 Bil |